SRC and malignant colon neoplasm: Mezquita et al. demonstrated that LDV and DCV are particularly effective in inhibiting proliferation, invasion, and colony formation in triple-negative MDA-MB-231 breast cancer cells, SRC-transduced SW620 colon cancer cells, and SRC-transduced NIH3T3 fibroblasts, suggesting potential therapeutic applications in Src-associated tumors [86].